Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.24.1.1.u2
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Compensation  
Schedule of stock options

    

    

    

    

    

Weighted

 

Average

 

Weighted

 

Remaining

 

Average

 

Contractual

 

Number of

 

Exercise

 

Term

 

Shares

 

Price

 

(Years)

Outstanding at December 31, 2023

 

1,651,147

$

4.78

 

8.08

Granted

 

375,775

 

0.36

 

Exercised

 

 

 

Outstanding at March 31, 2024

 

2,026,922

$

3.96

 

8.21

Exercisable at March 31, 2024

 

1,142,978

$

6.37

 

7.47

Schedule of underwriters warrants to purchase common shares

    

    

    

    

    

Weighted

 

Average

 

Weighted

 

Remaining

 

Average

 

Contractual

 

Number of

 

Exercise

 

Term

 

Shares

 

Price

 

(Years)

Outstanding at December 31, 2023

 

193,875

$

11.19

 

2.16

Granted

 

 

 

Outstanding at March 31, 2024

 

193,875

$

11.19

 

1.91

Exercisable at March 31, 2024

 

193,875

$

11.19

 

1.91